This site is intended for health professionals only
Tuesday 25 September 2018

Kathy Oxtoby

Articles by this author

Thu 5 July
Thu 5 July
Cimzia can be used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, following label extension by European Medicines Agency (EMA)
Wed 4 July
Wed 4 July
A clinical trial to treat female diffuse hair loss has been kick started by US regenerative medicine company Histogen.
Thu 28 June
Thu 28 June
First patient with metastatic breast cancer receives treatment to look at anti-tumour effect and tolerability using new drug response predictor
Thu 28 June
Thu 28 June
First cannabinoid prescription medicine to be approved in the US endorses Epidiolex to treat two rare forms of childhood-onset epilepsy
Wed 27 June
Wed 27 June
Oral Semaglutide demonstrates significant reduction in blood sugar versus placebo in trial
Thu 21 June
Thu 21 June
Targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors
Thu 21 June
Thu 21 June
Global pharmaceutical company to discontinue a late-stage trial assessing the efficacy of an experimental therapy in reducing chronic cluster headaches.
Wed 20 June
Wed 20 June
Idorsia launches PRECISION – Phase 3 study with aprocitentan for resistant hypertension management in adults
Thu 14 June
Thu 14 June
International team of researchers have developed new DNA test to identify men at greatest risk of prostate cancer
Thu 14 June
Thu 14 June
Cancer fighting effects of aspirin revealed in bowel tumour study
Wed 6 June
Wed 6 June
Evidence on whether cabozantinib increases the overall length of time people live is “less certain” says the National Institute for Health and Care Excellence
Wed 6 June
Wed 6 June
First monoclonal antibody therapy for prevention of migraine
Fri 1 June
Fri 1 June
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumors
Fri 1 June
Fri 1 June
Health and Social Care Committee identifies key areas associated with childhood obesity, which demand urgent attention from government
Fri 1 June
Fri 1 June
Based on a recent planned review, the Data Monitoring Committee (DMC) recommends termination of Phase Ib/II study of daratumumab plus atezolizumab (anti PD-L1 antibody) in patients with previously treated non-small cell lung cancer
Thu 24 May
Thu 24 May
Children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones, paediatric researchers have found
Thu 24 May
Thu 24 May
European programme to help people access edaravone for ALS treatment established by pharmaceutical companies
Thu 24 May
Thu 24 May
Juluca (dolutegravir/rilpivirine), has been endorsed as the first 2-drug regimen, once-daily, single-pill for the treatment of HIV